Evidence map›Paper›PMID 33627058›Full record

ReviewVascular medicine (London, England)2021

Treatment decisions for patients with peripheral artery disease and symptoms of claudication: Development process and alpha testing of the SHOW-ME PAD decision aid.

Kim G Smolderen, Christina Pacheco, Jeremy Provance, Nancy Stone, Christine Fuss, Carole Decker, Matthew Bunte, Qurat-Ul-Ain Jelani, David M Safley, Eric Secemsky and 4 more

Open access · greenAbstract readReview
In one paragraph

Review in Vascular medicine (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Kim G SmolderenDepartment of Internal Medicine, Vascular Medicine Outcomes (VAMOS) Program, Cardiovascular Medicine Section, Yale University, New Haven, CT, USA.ORCID 0000-0001-6104-6254
Christina PachecoSaint Luke's Mid America Heart Institute, Kansas City, MO, USA.
Jeremy ProvanceSchool of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.ORCID 0000-0002-2734-4634
Nancy StoneSaint Luke's Mid America Heart Institute, Kansas City, MO, USA.
Christine FussSaint Luke's Mid America Heart Institute, Kansas City, MO, USA.
Carole DeckerSaint Luke's Mid America Heart Institute, Kansas City, MO, USA.
Matthew BunteSaint Luke's Mid America Heart Institute, Kansas City, MO, USA.
Qurat-Ul-Ain JelaniDepartment of Internal Medicine, Vascular Medicine Outcomes (VAMOS) Program, Cardiovascular Medicine Section, Yale University, New Haven, CT, USA.ORCID 0000-0003-3393-8348
David M SafleySaint Luke's Mid America Heart Institute, Kansas City, MO, USA.
Eric SecemskyBeth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0003-3861-3163
Karen R SepuchaDana Farber/Harvard Cancer Center, Massachusetts General Hospital, Boston, MA, USA.
Erica S SpatzDepartment of Internal Medicine, Cardiovascular Medicine Section Yale University/Center for Outcomes Research and Evaluation, Yale New Haven Health Hospital, New Haven, CT, USA.
Carlos Mena-HurtadoDepartment of Internal Medicine, Vascular Medicine Outcomes (VAMOS) Program, Cardiovascular Medicine Section, Yale University, New Haven, CT, USA.
John A SpertusSaint Luke's Mid America Heart Institute, Kansas City, MO, USA.
Saint Luke's Hospital · USYale University · USBeth Israel Deaconess Medical Center · USMassachusetts General Hospital · USUniversity of Missouri–Kansas City · USYale New Haven Hospital · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Shared Decision-Making to Improve the Health Status of Patients with Claudication: Developing and Implementing Strategies to Individualize Treatment DecisionsK23HL150290 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SECEMSKY, ERIC ALEXANDER · 2020 to 2024
$851k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS K23 HL150290
6 · The paper itself

Abstract

Patients with peripheral artery disease (PAD) face a range of treatment options to improve survival and quality of life. An evidence-based shared decision-making tool (brochure, website, and recorded patient vignettes) for patients with new or worsening claudication symptoms was created using mixed methods and following the International Patient Decision Aids Standards (IPDAS) criteria. We reviewed literature and collected qualitative input from patients (

Indexed as

Peripheral Arterial DiseaseQuality of LifeDecision Support TechniquesHumansIntermittent ClaudicationSurveys and Questionnairesclaudicationpatient centeredpatient educationperipheral artery disease (PAD)shared decision-making

Identifiers

PMID33627058
PMCPMC8169642
OpenAlexW3130678687

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.